KBC Group
IRWD icon

KBC Group’s Ironwood Pharmaceuticals IRWD Stock Holding History

KBC Group’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-8,593
Closed -$35K – 1848
2024
Q3 		$35K Buy
8,593
+3,198
+59% +$17.2K ﹤0.01% 1812
2024
Q2 		$35K Buy
5,395
+627
+13% +$4.43K ﹤0.01% 1780
2024
Q1 		$42K Hold
4,768
– – ﹤0.01% 1640
2023
Q4 		$55K Hold
4,768
– – ﹤0.01% 1455
2023
Q3 		$46K Sell
4,768
-6,277
-57% -$61.5K ﹤0.01% 1508
2023
Q2 		$118K Hold
11,045
– – ﹤0.01% 1119
2023
Q1 		$116K Sell
11,045
-1,424
-11% -$16K ﹤0.01% 1156
2022
Q4 		$154K Hold
12,469
– – ﹤0.01% 1052
2022
Q3 		$129K Buy
+12,469
New +$141K ﹤0.01% 1091

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

KBC Group's IRWD Position: Q4 2024 in Review

KBC Group sold out of Ironwood Pharmaceuticals (IRWD) in Q4 2024, closing a stake of 8,593 shares — an estimated $35K sold.

KBC Group first reported a position in IRWD in Q3 2022 and held it in 9 quarters. The position peaked at $154K in Q4 2022. 223 funds tracked by Wall St. Rank hold IRWD as of Q4 2024.

  • KBC Group reported no remaining Ironwood Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • KBC Group sold 8,593 Ironwood Pharmaceuticals shares in Q4 2024, an estimated $35K.
  • KBC Group first reported a position in Ironwood Pharmaceuticals in Q3 2022 and held it in 9 quarters.
  • KBC Group's Ironwood Pharmaceuticals position peaked at $154K in Q4 2022.
  • 223 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2024.

Based on KBC Group's 13F filing for Q4 2024, filed 22 Jan 2025.